Piper Jaffray Companies reiterated their buy rating on shares of SeaSpine Holdings Corporation (NASDAQ:SPNE) in a research note published on Sunday morning. Piper Jaffray Companies currently has a $22.00 price objective on the medical equipment provider’s stock.
A number of other brokerages also recently issued reports on SPNE. HC Wainwright set a $15.00 price target on SeaSpine Holdings Corporation and gave the company a buy rating in a report on Monday, August 7th. ValuEngine raised SeaSpine Holdings Corporation from a strong sell rating to a sell rating in a report on Friday, June 2nd. Finally, BTIG Research began coverage on SeaSpine Holdings Corporation in a report on Tuesday, June 20th. They set a buy rating on the stock.
SeaSpine Holdings Corporation (NASDAQ SPNE) opened at 11.67 on Friday. The company’s market capitalization is $146.47 million. The firm’s 50-day moving average price is $12.09 and its 200 day moving average price is $9.33. SeaSpine Holdings Corporation has a 52 week low of $6.31 and a 52 week high of $13.46.
COPYRIGHT VIOLATION NOTICE: This piece was originally reported by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece on another site, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The original version of this piece can be read at https://stocknewstimes.com/2017/08/21/seaspine-holdings-corporation-spne-receives-buy-rating-from-piper-jaffray-companies.html.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Dimensional Fund Advisors LP increased its position in shares of SeaSpine Holdings Corporation by 22.9% in the second quarter. Dimensional Fund Advisors LP now owns 368,631 shares of the medical equipment provider’s stock worth $4,247,000 after buying an additional 68,737 shares during the last quarter. Virtu KCG Holdings LLC acquired a new position in shares of SeaSpine Holdings Corporation during the second quarter worth about $133,000. Vanguard Group Inc. increased its position in shares of SeaSpine Holdings Corporation by 10.6% in the second quarter. Vanguard Group Inc. now owns 334,832 shares of the medical equipment provider’s stock worth $3,857,000 after buying an additional 32,191 shares during the last quarter. Northern Trust Corp increased its position in shares of SeaSpine Holdings Corporation by 2.3% in the second quarter. Northern Trust Corp now owns 24,869 shares of the medical equipment provider’s stock worth $286,000 after buying an additional 559 shares during the last quarter. Finally, UBS Asset Management Americas Inc. increased its position in shares of SeaSpine Holdings Corporation by 1.7% in the second quarter. UBS Asset Management Americas Inc. now owns 134,891 shares of the medical equipment provider’s stock worth $1,554,000 after buying an additional 2,209 shares during the last quarter. 45.29% of the stock is currently owned by hedge funds and other institutional investors.
SeaSpine Holdings Corporation Company Profile
SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment.
Receive News & Ratings for SeaSpine Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine Holdings Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
